Bevacizumab improves pathological response of colorectal cancer liver metastases treated with XELOX/FOLFOX. (Q43153223)

From Wikidata
Jump to: navigation, search
scientific article published on 23 February 2010
edit
Language Label Description Also known as
English
Bevacizumab improves pathological response of colorectal cancer liver metastases treated with XELOX/FOLFOX.
scientific article published on 23 February 2010

    Statements

    Bevacizumab improves pathological response of colorectal cancer liver metastases treated with XELOX/FOLFOX. (English)
    Markus Klinger
    Dietmar Tamandl
    Sandra Eipeldauer
    Beata Herberger
    Klaus Kaczirek
    Marion Dorfmeister
    Birgit Gruenberger
    Thomas Gruenberger
    23 February 2010
    2059-2065

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit